nadolol
nadolol
| SMILES | CC(C)(C)NCC(O)COc1cccc2c1C[C@H](O)[C@H](O)C2 |
| InChIKey | VWPOSFSPZNDTMJ-UCWKZMIHSA-N |
Chemical Properties
| Hydrogen bond acceptors | 5 |
| Hydrogen bond donors | 4 |
| Rotatable bonds | 5 |
| Molecular weight (Da) | 309.2 |
Database connections
| Ligand site mutations | β3 |
No bioactivity data available.
nadolol
Drug properties
| Molecular type | Small molecule |
| Physiological/Surrogate | Surrogate |
| Approved drug | Yes |
Distribution across phases (no. indications)
Phase I
0
Phase II
4
Phase III
2
Phase IV
11
Database connections
| Ligand site mutations | β3 |
Sankey plot
, 'sankey.svg');){kind=link}
, 'sankey.png');){kind=link}
,'sankey.jpg');){kind=link}
Drug Information
| Target | Disease | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Gene | Protein | Receptor family | Ligand type | Class | Name | Phase | ICD11 | ATC | Association score |